☰

Divya Pathania, Ph.D. - Publications

Affiliations: 
2013 Pharmacy/Pharmaceutical Sciences University of Southern California, Los Angeles, CA, United States 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Huang CH, Park YI, Lin HY, Pathania D, Park KS, Avila-Wallace M, Castro CM, Weissleder R, Lee H. Compact and Filter-Free Luminescence Biosensor for Mobile Diagnoses. Acs Nano. PMID 31461265 DOI: 10.1021/Acsnano.9B05634  0.333
2018 Giedt RJ, Pathania D, Carlson JCT, McFarland PJ, Del Castillo AF, Juric D, Weissleder R. Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimens. Nature Communications. 9: 4550. PMID 30382095 DOI: 10.1038/S41467-018-07002-6  0.418
2018 Min J, Im H, Allen M, McFarland PJ, Degani I, Yu H, Normandin E, Pathania D, Patel J, Castro CM, Weissleder R, Lee H. Computational Optics Enables Breast Cancer Profiling in Point-Of-Care Settings. Acs Nano. PMID 30113824 DOI: 10.1021/Acsnano.8B03029  0.385
2016 Giedt RJ, Fumene Feruglio P, Pathania D, Yang KS, Kilcoyne A, Vinegoni C, Mitchison TJ, Weissleder R. Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response. Scientific Reports. 6: 32985. PMID 27609668 DOI: 10.1038/Srep32985  0.479
2016 Pathania D, Im H, Kilcoyne A, Sohani AR, Fexon L, Pivovarov M, Abramson JS, Randall TC, Chabner BA, Weissleder R, Lee H, Castro CM. Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field Applications. Theranostics. 6: 1603-10. PMID 27446494 DOI: 10.7150/Thno.15534  0.316
2016 Sanna V, Nurra S, Pala N, Marceddu S, Pathania D, Neamati N, Sechi M. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. Journal of Medicinal Chemistry. PMID 27139920 DOI: 10.1021/Acs.Jmedchem.5B01571  0.572
2016 Giedt RJ, Fergulio PF, Pathania D, Yang KS, Kilcoyne A, Vinegoni C, Mitchison TJ, Weissleder R. Abstract 234: Mitochondrial morphology as a biomarker of cancer phenotype and drug response Cancer Research. 76: 234-234. DOI: 10.1158/1538-7445.Am2016-234  0.497
2015 Pathania D, Kuang Y, Sechi M, Neamati N. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. British Journal of Pharmacology. 172: 50-63. PMID 25047070 DOI: 10.1111/Bph.12855  0.625
2014 Pathania D, Sechi M, Palomba M, Sanna V, Berrettini F, Sias A, Taheri L, Neamati N. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Biochimica Et Biophysica Acta. 1840: 332-43. PMID 23954204 DOI: 10.1016/J.Bbagen.2013.08.005  0.608
2013 Pathania D, Sechi M, Palomba M, Sanna V, Berrettini F, Sias A, Taheri L, Neamati N. Abstract 4555: Design and discovery of novel small molecule redox modulators as therapies for pancreatic cancer. Cancer Research. 73: 4555-4555. DOI: 10.1158/1538-7445.Am2013-4555  0.667
2011 Millard M, Pathania D, Grande F, Xu S, Neamati N. Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 update. Current Pharmaceutical Design. 17: 536-59. PMID 21391905 DOI: 10.2174/138161211795222649  0.663
2011 Pathania D, Sechi M, Palomba M, Cosseddu A, Sanna V, Berrettini F, Sias A, Taheri L, Neamati N. Abstract 682: Design and discovery of novel small molecule modulators of reactive oxygen species-mediated cell signaling Cancer Research. 71: 682-682. DOI: 10.1158/1538-7445.Am2011-682  0.671
2011 Millard M, Pathania D, Shabaik Y, Taheri L, Deng J, Neamati N. Abstract 2542: Preclinical studies of novel phosphonium salts with broad-spectrum activity Cancer Research. 71: 2542-2542. DOI: 10.1158/1538-7445.Am2011-2542  0.657
2010 Millard M, Pathania D, Shabaik Y, Taheri L, Deng J, Neamati N. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. Plos One. 5. PMID 20957228 DOI: 10.1371/Journal.Pone.0013131  0.64
2009 Pathania D, Millard M, Neamati N. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Advanced Drug Delivery Reviews. 61: 1250-75. PMID 19716393 DOI: 10.1016/J.Addr.2009.05.010  0.739
Show low-probability matches.